Issue 6/2020
Content (9 Articles)
Objective evaluation for treat to target in Crohn’s disease
Kento Takenaka, Yoshio Kitazume, Toshimitsu Fujii, Kiichiro Tsuchiya, Mamoru Watanabe, Kazuo Ohtsuka
Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities
Mette Vesterhus, Tom Hemming Karlsen
A nationwide, multi-center, retrospective study of symptomatic small bowel stricture in patients with Crohn’s disease
Shigeki Bamba, Ryosuke Sakemi, Toshimitsu Fujii, Teruyuki Takeda, Shin Fujioka, Kento Takenaka, Hiroki Kitamoto, Shotaro Umezawa, Hirotake Sakuraba, Toshihiro Inokuchi, Norimasa Fukata, Shinta Mizuno, Masaki Yamashita, Shinichiro Shinzaki, Hiroki Tanaka, Hidetoshi Takedatsu, Ryo Ozaki, Kei Moriya, Manabu Ishii, Tetsu Kinjo, Keiji Ozeki, Makoto Ooi, Ryohei Hayashi, Kazuki Kakimoto, Yuichi Shimodate, Kazuya Kitamura, Akihiro Yamada, Akira Sonoda, Yu Nishida, Kyouko Yoshioka, Shinya Ashizuka, Fumiaki Takahashi, Toshio Shimokawa, Taku Kobayashi, Akira Andoh, Toshifumi Hibi
Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial
Masatoshi Kudo, Takuji Okusaka, Kenta Motomura, Izumi Ohno, Manabu Morimoto, Satoru Seo, Yoshiyuki Wada, Shinpei Sato, Tatsuya Yamashita, Masayuki Furukawa, Takeshi Aramaki, Seijin Nadano, Kazuyoshi Ohkawa, Hirofumi Fujii, Toshihiro Kudo, Junji Furuse, Hiroki Takai, Gosuke Homma, Reigetsu Yoshikawa, Andrew X. Zhu
JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study
Tetsuo Takehara, Kazuaki Chayama, Masayuki Kurosaki, Hiroshi Yatsuhashi, Yasuhito Tanaka, Naoki Hiramatsu, Naoya Sakamoto, Yasuhiro Asahina, Akito Nozaki, Toshikazu Nakano, Yosuke Hagiwara, Hiroko Shimizu, Hiroki Yoshida, Yuhan Huang, Michael Biermer, Leen Vijgen, Norio Hayashi
Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies
Kazuyuki Mizuno, Takanori Ito, Masatoshi Ishigami, Yoji Ishizu, Teiji Kuzuya, Takashi Honda, Hiroki Kawashima, Yosuke Inukai, Hidenori Toyoda, Kenji Yokota, Tetsunari Hase, Osamu Maeda, Hitoshi Kiyoi, Masato Nagino, Hideharu Hibi, Yasuhiro Kodera, Yasushi Fujimoto, Michihiko Sone, Momokazu Gotoh, Yuichi Ando, Masashi Akiyama, Yoshinori Hasegawa, Mitsuhiro Fujishiro
Can portal hypertension and hepatic decompensation be predicted?
Kosuke Kaji, Hitoshi Yoshiji
Correction to: Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradication therapy
Kazuhiko Masuda, Yuji Urabe, Masanori Ito, Atsushi Ono, Hayes Clair Nelson, Koki Nakamura, Takahiro Kotachi, Tomoyuki Boda, Shinji Tanaka, Kazuaki Chayama